List of Excipients in Branded Drug SUNMARK

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Strategic Sourcing Services LLC	SUNMARK	clotrimazole	49348-379	BENZYL ALCOHOL
Strategic Sourcing Services LLC	SUNMARK	clotrimazole	49348-379	CETOSTEARYL ALCOHOL
Strategic Sourcing Services LLC	SUNMARK	clotrimazole	49348-379	CETYL ESTERS WAX
Strategic Sourcing Services LLC	SUNMARK	clotrimazole	49348-379	OCTYLDODECANOL
Strategic Sourcing Services LLC	SUNMARK	clotrimazole	49348-379	POLYSORBATE 60

Generic Drugs Containing SUNMARK

Company	Ingredient	NDC	Excipient
McKesson	cetirizine hydrochloride	49348-326	ACETIC ACID
McKesson	cetirizine hydrochloride	49348-326	GLYCERIN
McKesson	cetirizine hydrochloride	49348-326	METHYLPARABEN
McKesson	cetirizine hydrochloride	49348-326	PROPYLENE GLYCOL
McKesson	cetirizine hydrochloride	49348-326	PROPYLPARABEN

What are the Most Frequently-Used Excipients in SUNMARK?

# Of NDCs	Excipient
1	ACETIC ACID
2	CITRIC ACID MONOHYDRATE
4	GLYCERIN
1	METHYLPARABEN
1	PHOSPHORIC ACID

Excipient Strategy and Commercial Opportunities for SUNMARK

Last updated: February 25, 2026

What is the Current Excipient Framework for SUNMARK?

SUNMARK, a pharmaceutical generic, is formulated with an excipient profile aligned with standard industry practices for bioavailability and stability. Key excipients include:

• Lactose Monohydrate: Used as a filler and binder.
• Microcrystalline Cellulose: Disintegrant and filler.
• Magnesium Stearate: Lubricant.
• Starch: Disintegrant.

The excipient landscape is consistent with conventional solid oral dosage forms, ensuring regulatory compliance and manufacturing scalability.

How Can Excipient Selection Enhance SUNMARK’s Bioavailability and Patient Profile?

Strategic excipient choices impact drug performance:

• Disintegrants: Incorporating croscarmellose sodium can improve dissolution rates, especially for poorly soluble APIs.
• Solubilizers: Using surfactants like sodium lauryl sulfate can enhance drug solubility in the gastrointestinal tract.
• pH Modifiers: Including buffering agents to optimize local pH stability during transit.
• Taste Masking Agents: Adding sweeteners or flavors for better patient compliance, especially in pediatric formulations.

Modifying excipient compositions can serve as a differentiation factor, improving therapeutic efficacy or patient adherence.

What Are the Commercial Opportunities Through Excipient Innovation?

Emerging trends identify several avenues:

1. Developing Orally Disintegrating Tablets (ODTs)

Increased demand for patient-friendly dosage forms opens opportunities to reformulate SUNMARK into ODTs by adding superdisintegrants like crospovidone. This can command premium pricing and expand market access in pediatric and geriatric segments.

2. Enhanced Bioavailability

Incorporating lipid-based excipients or nanocarriers can address solubility issues, potentially allowing for dose reductions and improving therapeutic outcomes. Such innovations can justify higher price points.

3. Complex Formulations for Modified-Release Profiles

Using specialized excipients like ethylcellulose or hydroxypropyl methylcellulose to develop extended-release versions introduces patentability and competitive barriers, safeguarding market share long-term.

4. Excipient Cost Optimization

Switching to cost-effective excipients without compromising quality can improve margins. For instance, replacing synthetic lubricants with plant-based alternatives reduces supply chain risks and appeals to clean-label trends.

5. Sustainable Excipients and Green Chemistry

Incorporating biodegradable or plant-derived excipients aligns with regulatory shifts towards sustainability. This can facilitate faster approvals and appeal to environmentally conscious consumers.

Regulatory and Supply Chain Considerations

• Quality Control: Excipient sourcing must comply with ICH Q3D for elemental impurities.
• Supply Chain Stability: Diversify suppliers for critical excipients such as microcrystalline cellulose.
• Regulatory Documentation: Maintain detailed excipient profiles for regulatory filings (e.g., ANDA submissions).

Competitive Landscape and Intellectual Property

• Patents on specific excipient combinations or novel disintegrant formulations can provide exclusivity.
• Proprietary excipients command premium prices and reduce competition.

Market Dynamics and Growth Potential

Factor	Impact	Examples
Demographics	Aging populations increase demand for easy-to-administer forms	ODT formulations
Regulation	supports innovation in excipients for safety	FDA guidance on excipient safety profiles [1]
Sustainability	differentiates products, appeals to eco-conscious consumers	Use of natural gelling agents
Price Sensitivity	cost-effective excipients enhance competitiveness	Bulk purchasing, supply chain management

The global solid oral dosage form market is projected to reach $269 billion by 2025, with excipient innovations influencing a significant share of growth [2].

Key Takeaways

• Excipient selection directly influences SUNMARK’s bioavailability, stability, and patient acceptability.
• Innovations such as disintegrants and solubilizers can open markets for reformulation.
• Developing novel or sustained-release formulations offers patent opportunities and competitive advantages.
• Cost management and sustainability in excipients support profitability and market differentiation.
• Regulatory compliance and supply chain resilience are critical for successful excipient strategies.

FAQs

1. How does excipient choice impact SUNMARK’s regulatory approval process?
Excipient selection must meet regulatory standards regarding purity, safety, and stability. Clear documentation and compliance with ICH guidelines support approval.

2. Can excipient innovation extend SUNMARK’s patent life?
Yes. Novel excipient combinations or modified formulations can establish new patents, delaying generic competition.

3. What are the risks of switching excipients?
Potential risks include stability issues, bioavailability changes, and regulatory delays if formulations differ significantly. Stability testing and regulatory notifications are necessary.

4. How does sustainability influence excipient strategy?
Sustainable excipients may streamline regulatory approval and improve brand perception, creating a marketing advantage.

5. What are the key considerations for cost-effective excipient sourcing?
Ensuring consistent quality, diversifying suppliers, and optimizing procurement strategies lower costs and mitigate supply disruptions.

References

[1] U.S. Food and Drug Administration. (2021). Guidance for Industry: Nonclinical Safety Evaluation of Excipient Pharmaceuticals.
[2] Grand View Research. (2021). Solid Oral Dosage Form Market Size, Share & Trends Analysis.